Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy

• Egile Nagusiak: Lukas Amon (Egilea), Lukas Hatscher (Egilea), Lukas Heger (Egilea), Diana Dudziak (Egilea), Christian H. K. Lehmann (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2020-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The onset of checkpoint inhibition revolutionized the treatment of cancer. However, studies from the last decade suggested that the sole enhancement of T cell functionality might not suffice to fight malignancies in all individuals. Dendritic cells (DCs) are not only part of the innate immune system...